Carnegie Investment Counsel’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,850
Closed -$355K 434
2019
Q1
$355K Sell
4,850
-850
-15% -$61.3K 0.02% 345
2018
Q4
$384K Sell
5,700
-10,720
-65% -$757K 0.04% 291
2018
Q3
$1.19M Buy
16,420
+7,800
+90% +$624K 0.1% 182
2018
Q2
$690K Sell
8,620
-242
-3% -$18.1K 0.05% 241
2018
Q1
$688K Sell
8,862
-7,978
-47% -$531K 0.06% 222
2017
Q4
$1.12M Sell
16,840
-1,285
-7% -$91.6K 0.1% 204
2017
Q3
$1.47M Buy
18,125
+5,963
+49% +$454K 0.17% 149
2017
Q2
$935K Buy
12,162
+4,042
+50% +$282K 0.11% 185
2017
Q1
$560K Buy
+8,120
New +$439K 0.07% 225

Other funds holding MDSO

Carnegie Investment Counsel's MDSO Position: Q2 2019 in Review

Carnegie Investment Counsel sold out of Medidata Solutions, Inc. (MDSO) in Q2 2019, closing a stake of 4,850 shares — an estimated $355K sold.

Carnegie Investment Counsel first reported a position in MDSO in Q1 2017 and held it in 9 quarters. The position peaked at $1.47M in Q3 2017. 302 funds tracked by Wall St. Rank hold MDSO as of Q2 2019.

  • Carnegie Investment Counsel reported no remaining Medidata Solutions, Inc. position as of Q2 2019 after selling out during the quarter.
  • Carnegie Investment Counsel sold 4,850 Medidata Solutions, Inc. shares in Q2 2019, an estimated $355K.
  • Carnegie Investment Counsel first reported a position in Medidata Solutions, Inc. in Q1 2017 and held it in 9 quarters.
  • Carnegie Investment Counsel's Medidata Solutions, Inc. position peaked at $1.47M in Q3 2017.
  • 302 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q2 2019.

Based on Carnegie Investment Counsel's 13F filing for Q2 2019, filed 24 Jul 2019.